Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of i.v. thiopental use in psychiatric emergency settings in Japan.
Hatta K, Nakamura M, Yoshida K, Hamakawa H, Wakejima T, Nishimura T, Kawabata T, Hirata T, Usui C, Sawa Y. Hatta K, et al. Psychiatry Clin Neurosci. 2009 Oct;63(5):658-62. doi: 10.1111/j.1440-1819.2009.02010.x. Epub 2009 Aug 10. Psychiatry Clin Neurosci. 2009. PMID: 19674381 Free article.
Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia.
Hatta K, Otachi T, Sudo Y, Hayakawa T, Ashizawa Y, Takebayashi H, Hayashi N, Hamakawa H, Ito S, Nakase R, Usui C, Nakamura H, Hirata T, Sawa Y; JAST Study Group. Hatta K, et al. Schizophr Res. 2011 May;128(1-3):127-35. doi: 10.1016/j.schres.2011.02.011. Epub 2011 Mar 21. Schizophr Res. 2011. PMID: 21420283 Clinical Trial.
A comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone.
Hatta K, Otachi T, Sudo Y, Kuga H, Takebayashi H, Hayashi H, Ishii R, Kasuya M, Hayakawa T, Morikawa F, Hata K, Nakamura M, Usui C, Nakamura H, Hirata T, Sawa Y; JAST study group. Hatta K, et al. Psychiatry Res. 2012 Jul 30;198(2):194-201. doi: 10.1016/j.psychres.2012.01.006. Epub 2012 Mar 13. Psychiatry Res. 2012. PMID: 22421064 Clinical Trial.
The possibility that requiring high-dose olanzapine cannot be explained by pharmacokinetics in the treatment of acute-phase schizophrenia.
Hatta K, Takebayashi H, Sudo Y, Katayama S, Kasuya M, Shirai Y, Morikawa F, Nakase R, Nakamura M, Ito S, Kuga H, Nakamura M, Ohnuma T, Usui C, Nakamura H, Hirata T, Sawa Y; JAST study group. Hatta K, et al. Psychiatry Res. 2013 Dec 15;210(2):396-401. doi: 10.1016/j.psychres.2013.07.005. Epub 2013 Aug 4. Psychiatry Res. 2013. PMID: 23919898 Clinical Trial.
Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.
Hatta K, Otachi T, Fujita K, Morikawa F, Ito S, Tomiyama H, Abe T, Sudo Y, Takebayashi H, Yamashita T, Katayama S, Nakase R, Shirai Y, Usui C, Nakamura H, Ito H, Hirata T, Sawa Y; JAST study group. Hatta K, et al. Schizophr Res. 2014 Sep;158(1-3):213-22. doi: 10.1016/j.schres.2014.07.015. Epub 2014 Jul 31. Schizophr Res. 2014. PMID: 25086659 Free article. Clinical Trial.
311 results